Cargando…
A Phase IIb Randomized Controlled Trial Investigating the Effects of Tocotrienol-Rich Vitamin E on Diabetic Kidney Disease
Diabetic kidney disease (DKD) is a debilitating complication of diabetes, which develops in 40% of the diabetic population and is responsible for up to 50% of end-stage renal disease (ESRD). Tocotrienols have shown to be a potent antioxidant, anti-inflammatory, and antifibrotic agent in animal and c...
Autores principales: | Koay, Yan Yi, Tan, Gerald Chen Jie, Phang, Sonia Chew Wen, Ho, J-Ian, Chuar, Pei Fen, Ho, Loon Shin, Ahmad, Badariah, Abdul Kadir, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830596/ https://www.ncbi.nlm.nih.gov/pubmed/33477404 http://dx.doi.org/10.3390/nu13010258 |
Ejemplares similares
-
Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial
por: Chuar, Pei Fen, et al.
Publicado: (2021) -
The effects of vitamin E on non-proliferative diabetic retinopathy in type 2 diabetes mellitus: Are they sustainable with 12 months of therapy
por: Ho, J-Ian, et al.
Publicado: (2022) -
The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial
por: Ng, Yeek Tat, et al.
Publicado: (2020) -
Tocotrienol-rich vitamin E improves diabetic nephropathy and persists
6–9 months after washout: a phase IIa randomized controlled
trial
por: Tan, Gerald Chen Jie, et al.
Publicado: (2019) -
Effects of Tocotrienol-Rich Fraction Supplementation in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Phang, Sonia C.W., et al.
Publicado: (2023)